PLK4 Identified as Potential TP53 AML Treatment by HKUMed :

PLK4 Identified as Potential TP53 AML Treatment by HKUMed

PLK4 Identified as Potential TP53 AML Treatment by HKUMed

miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Canada , Toronto , Ontario , London , City Of , United Kingdom , Hong Kong , Kenny Dang , Michael Huen Shing Yan , School Of Biomedical Sciences , Li Shu Fan Medical Foundation , Centre For Oncology , Sk Yee Medical Foundation , Madam Madeline Tong Lai Sheung Cancer Research Fund , King College London , Department Of Medicine , Research Scheme , Blood Cancer Fund , School Of Clinical Medicine , Princess Margaret Cancer Centre , Hong Kong Research Grants Council , University Of Hong Kong Hkumed , Haematology Division At Queen Mary Hospital , Tang King Yin Research Fund , Technology Commission , Department Of Pathology , Croucher Foundation , Ying Wan Leung Research Fund , Research Assistant Professor , Professor Anskar Leung Yu Hung , Clinical Medicine , Mary Hospital , Haematology Division , Queen Mary Hospital , Chair Professor , Eunis Lam , Associate Professor , Professor Michael Huen Shing Yan , Biomedical Sciences , College London , Professor Mak Tak Wah , Theme Based Research Scheme , Blood Cancer ,